Gonzalo Esquivias-Baron
Sevilla, AN 41013, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
Edoxaban for Stroke Prevention in Atrial Fibrillation in Spain and Portugal: 4-Year Follow-Up of the Observational ETNA-AF-Europe Study.
Journal: Journal of clinical medicine
Published: March 10, 2026
Sleeping and the risk of atrial fibrillation: a prospective study in the SUN cohort.
Journal: European journal of preventive cardiology
Published: March 27, 2025
Rhythm versus rate control in patients with newly diagnosed atrial fibrillation - Observations from the GARFIELD-AF registry.
Journal: International journal of cardiology. Heart & vasculature
Published: November 06, 2023
Incidence and Predictors of Worsening Renal Function in Edoxaban-Treated Atrial Fibrillation Patients Within ETNA-AF-Europe Registry.
Journal: JACC. Advances
Published: June 26, 2023
Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban.
Journal: Journal of comparative effectiveness research
Published: February 07, 2023
Adverse Clinical Outcomes and Associated Predictors in Rivaroxaban-Treated Atrial Fibrillation Patients With Renal Impairment.
Journal: The American journal of cardiology
Published: January 23, 2023
Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registries.
Journal: Journal of comparative effectiveness research
Published: September 23, 2022
Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study.
Journal: Cardiology journal
Published: May 20, 2022
Use of rivaroxaban attenuates renal function impairment in patients with atrial fibrillation: insights of the EMIR study.
Journal: European journal of clinical investigation
Published: February 04, 2022
Outcomes and predictive value of the 2MACE score in patients with atrial fibrillation treated with rivaroxaban in a prospective, multicenter observational study: The EMIR study.
Journal: Cardiology journal
Published: January 07, 2022
Efficacy of exercise in patients with atrial fibrillation: Systematic review and meta-analysis.
Journal: Medicina clinica
Published: September 16, 2021
Predicted Value of MicroRNAs, Vascular Endothelial Growth Factor, and Intermediate Monocytes in the Left Adverse Ventricular Remodeling in Revascularized ST-Segment Elevation Myocardial Infarction Patients.
Journal: Frontiers in cardiovascular medicine
Published: September 15, 2021
Last Updated: 09/26/2026